Cinzia Dello Russo

11PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersPharmacogenomicsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 02, 2026
UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).

|May 13, 2026
ACKR1/Duffy-null genotype testing for clozapine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).

|May 11, 2026
Limited Visibility and Perception of the Clinical Relevance of Clopidogrel Pharmacogenetics in Cardiology Literature.

|Apr 19, 2026
HLA genotype testing for carbamazepine, oxcarbazepine and eslicarbazepine: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).

|Jan 31, 2026
Main factors associated with variability in the assessment of the objective response rate. A re-analysis of the PHEREXA phase 3 clinical trial.

Gennaro Daniele, Tommaso Giovagnoli, Pierluigi Navarra

|Dec 03, 2025
CYP2C19 genotype testing for clopidogrel: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).

Cinzia Dello Russo, Iain Frater, Rebecca Kuruvilla

Pageof 2

Frequent Collaborators

6 joint publications

Munir Pirmohamed

4 joint publications

Dyfrig A Hughes

2 joint publications

Pierluigi Navarra

1 joint publications

Lucia Lisi